Suppr超能文献

再次心脏瓣膜手术——现状与未来展望

Redo valve surgery--current status and future perspectives.

作者信息

Furukawa Hiroshi, Tanemoto Kazuo

机构信息

Kawasaki Medical School, Kurashiki, Okayama, Japan.

出版信息

Ann Thorac Cardiovasc Surg. 2014;20(4):267-75. doi: 10.5761/atcs.ra.13-00380.

Abstract

Surgeons are now facing the challenge of redo valve surgery because of the increasing number of elderly individuals in Japan. The incidence of bioprosthesis dysfunction has increased among the various surgical indications of redo valve surgery due to the preference of patients and a paradigm shift in prostheses from mechanical valves to bioprostheses. Previous studies reported that the clinical outcomes of reoperative valvular surgery have markedly improved due to the maneuver of myocardial protection, cardiopulmonary bypass strategies, and appropriate safer surgical approach. The general surgical outcomes of redo valve surgery have been reported as being similar to those of primary valve surgery; however, this is still controversial and has not yet been confirmed in some developed countries. Although the unique surgical technique of transcatheter valve-in-valve implantation for bioprosthetic dysfunction is promising, redo valve surgery may become more prevalent in the future. We here reviewed the current status of reoperative valve surgery and future perspectives including catheter-based surgical interventions.

摘要

由于日本老年人口数量的增加,外科医生目前正面临再次进行瓣膜手术的挑战。在再次进行瓣膜手术的各种手术指征中,由于患者的偏好以及假体从机械瓣膜向生物瓣膜的范式转变,生物假体功能障碍的发生率有所上升。先前的研究报告称,由于心肌保护策略、体外循环策略以及适当更安全的手术方法,再次进行瓣膜手术的临床结果有了显著改善。再次进行瓣膜手术的总体手术结果已报告与初次瓣膜手术相似;然而,这仍然存在争议,并且在一些发达国家尚未得到证实。尽管经导管瓣膜内瓣膜植入治疗生物假体功能障碍的独特手术技术很有前景,但再次进行瓣膜手术在未来可能会变得更加普遍。我们在此回顾了再次进行瓣膜手术的现状以及包括基于导管的手术干预在内的未来前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验